Bankrolled and Executing, Plus Products Looks to Finish 2019 Strong

---

---

By nearly all measures, the last eight months have been tough sledding for cannabis stocks. For example, the Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) is down 59.6% from its March high. Across the same span, the North American Marijuana Index has skidded 62.6%.

In depressed markets, there are always opportunities.

What started as shorters – traders that benefit from a stock price going down – piling up positions on bloated valuations as major companies were under-delivering on overblown promises, has been fueled by some real-life issues. Black market sales are remaining strong by drug dealers undercutting legal prices. The roll-out of adult use marijuana in Canada has been slower than expected. Furthermore, the CannTrust (NYSE:CTST)(TSX:TRST) scandal this summer shook investor confidence.

Know what this is? Normal for any emerging market. Just because the cannabis industry hasn’t gone from 0-100 mph in 3 seconds like some thought it would, doesn’t mean that it hasn’t advanced rapidly. Scandals will fade away. Prices will come down. Things like Canadian regulators moving slowly to get more stores open and allow new forms of cannabis to come to market will one day be a thing of the past. Remember, Canada became the first G20 country in history to legalize marijuana just 13 months ago.

This pullback could be the best thing to ever happen to cannabis, especially for investors that thought they missed the boat on the first climb in so-called pot stocks. Companies have been re-valuated by analysts now that there is some history to judge progress against. Now there is a more level playing field as expectations are more realistic. At the same time, companies like Plus Products, Inc. (CSE: PLUS)(OTCQX: PLPRF), a hyper-focused consumer packaged goods company, continue to make positive progress, grow sales and strengthen the team.

Click here to see the company investor presentation

#1. Literally.

Plus Products has initially focused its efforts on commercializing its cannabis products in California, the world’s sixth largest GDP and the largest legal marijuana markets on the planet. And it has done so spectacularly in a fiercely competitive market.

Over the last 12 months, Plus uplift cannabis-infused gummies (100mg THC, <2mg CBD) are the best-selling cannabis product in California as measured by BDS Analytics GreenEdge Platform, the authority in legal marijuana statistics. It was the fifth straight quarter the gummy held the top spot. The product is not only the best-selling gummy in California, it is the top-selling consumable cannabis product by dollar of retail sales across every market tracked by BDS Analytics.

Click here to see the company investor presentation

No other gummy is even close when it comes to volume. The Plus Uplift gummy SKU outsells the next closest gummy SKU competitor by two-fold.

Rounding out the top two gummies in CA is Plus unwind (90mg THC, 10mg CBD). Unwind also weighs in as the #1 selling CBD-inclusive gummy in California across the last 12 months.

Since sales began last year, more than 2.5 million units of Plus gummies have been sold in California.

The success has largely been organic, with the first high profile marketing efforts (billboards throughout San Francisco and Los Angeles) only recently launched.

New Markets on Tap

With these products dominating the market, Plus is moving into the next stage of development, launching new products (including a hemp-derived CBD line), new flavors and expanding into new markets – including ecommerce with a new online store for CBD products – as it becomes a truly national brand.

To penetrate the lucrative Nevada markets, a manufacturing partnership was forged in October with licensed producer TapRoot Holdings, with oversight from Plus management to ensure consistency with the popular CA products.

Also in the crosshairs are Arizona, Michigan, New York, Illinois and Massachusetts, with plans for international expansion starting with Canada.

Full Coffers

Plus is not like so many other upstarts that spend more time explaining what they intend to do, even though they don’t have a clear path or the capital to do so. Plus ended the second quarter with $34.1 million in cash and cash equivalents, which management believes is enough capital to continue executing on its model for over a full year.

Click here to see the company investor presentation

This cash is further backstopped by growing sales. During the latest reported quarter (ended June 30, 2019), Plus posted revenue of $3.58 million, an improvement of 126% from $1.58 million in the year prior quarter.

In the dogfight world of retail cannabis, Plus even figured out a way to improve margins through operational efficiency. Gross margins improved to $700,000, or 20%, compared to $200,000, or 14%, in Q2 2018.

The Venerable Team

Plus could confidently say that its leadership team was comprised of successful entrepreneurs, legal heavyweights, financial experts and strategic specialists before October began. Since then, the team has been made even stronger as the company attracts top-notch talent.

In October, Plus created the new position of Chief Scientific Officer, onboarding Dr. Ari Mackler to fill the role and spearhead evidenced-based edible cannabis research efforts across the entire PLUS Products portfolio of products. Dr. Mackler brings 20 years of medical affairs, communications and research experience in pharmaceutical, healthcare, and consumer goods industries to his new job that he earned during time at esteemed companies like Merck & Co. (NYSE: MRK) and The Wonderful Company and organizations like the Almond Board of California.

That was followed by Jill Braff, President of Brit + Co, joining Plus Products’ Board of Directors this month. To understand what Braff brings to the table to catapult Plus Products’ online sales channel only takes knowing that she has served as Executive Vice President of Digital Commerce at HSN; General Manager of Ellen (DeGeneres) Digital Ventures; and Vice President of Marketing at Ancestry.com before taking her current position at Brit + Co.

Click here to see the company investor presentation

No Excuses

Many of the major cannabis companies today are in a corner explaining to investors why they aren’t hitting the targets they have promised throughout the years. Not Plus Products. Their narrative only needs to consist about facts such as operational cash, best-selling products, a stellar team and its precision execution to date.

Click Here to Receive CFN Media’s Newsletter Every Week in Your Inbox

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://cannabisfn.com(the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.

 

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

---

Search CannabisFN

Press Coverage

Psychedelics Index

Top Videos

Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer